A. Hotze

发表

Sodium chains as core nanowires for gelation of organic solvents from a functionalized nicotinic acid and its sodium salt.

B. Kariuki, D. Bardelang, B. Paik, 2007, Chemistry.

Structure-dependent in vitro cytotoxicity of the isomeric complexes [Ru(L)2Cl2] (L=o-tolylazopyridine and 4-methyl-2-phenylazopyridine) in comparison to [Ru(azpy)2Cl2]

A. Spek, J. G. Haasnoot, M. Bacac, 2004, JBIC Journal of Biological Inorganic Chemistry.

Synthesis and cytotoxicity of dinuclear complexes containing ruthenium(II) bipyridyl units linked by a bis(pyridylimine) ligand.

M. Hicks, A. Rodger, M. J. Hannon, 2008, Dalton transactions.

Far-red luminescent ruthenium pyridylimine complexes; building blocks for multinuclear arrays.

Jonathan A. Faiz, G. Clarkson, K. Yannakopoulou, 2006, Dalton transactions.

Ligands rock & roll: stepwise twisting of two cis-coordinated lopsided N-heterocycles in an octahedral bis(2-phenylazopyridine)-ruthenium(II) complex with seven atropisomers.

J. Reedijk, A. Velders, A. Hotze, 2005, Chemistry.

Struggling or Succeeding in Science and Technology Education: Elementary School Students’ Individual Differences During Inquiry- and Design-Based Learning

M. Raijmakers, M. Dobber, A. Hotze, 2022, Frontiers in Education.

Electron capture dissociation mass spectrometry of metallo-supramolecular complexes

H. Cooper, Małgorzata A Kaczorowska, M. J. Hannon, 2010, Journal of the American Society for Mass Spectrometry.

Dinuclear ruthenium(II) triple-stranded helicates: luminescent supramolecular cylinders that bind and coil DNA and exhibit activity against cancer cell lines.

B. Kariuki, G. Pascu, Carlos Sanchez‐Cano, 2007, Angewandte Chemie.

Dinuclear double-stranded metallosupramolecular ruthenium complexes: potential anticancer drugs.

B. Kariuki, M. J. Hannon, A. Hotze, 2006, Angewandte Chemie.

Supramolecular iron cylinder with unprecedented DNA binding is a potent cytostatic and apoptotic agent without exhibiting genotoxicity.

R. Hayden, C. Bunce, J. Chipman, 2008, Chemistry & biology.

Coordination of 9-ethylguanine to the mixed-ligand compound alpha-[Ru(azpy)(bpy)Cl2] (azpy = 2-phenylazopyridine and bpy = 2,2'-bipyridine). An unprecedented ligand positional shift, correlated to the cytotoxicity of this type of [RuL2Cl2] (with L = azpy or bpy) complex.

Erwin P. L. van der Geer, A. Spek, J. G. Haasnoot, 2004, Inorganic chemistry.

Synthesis and characterization of ruthenium(II) complexes with the new ligand 2-phenylazopyridine-5-sulfonic acid (HSAZPY): in search for new anticancer agents

A. Spek, J. G. Haasnoot, J. Reedijk, 2004 .

Dichlorobis(2-phenylazopyridine)ruthenium(II) complexes: characterisation, spectroscopic and structural properties of four isomers.

A. Spek, J. Reedijk, A. Velders, 2004, Dalton transactions.

New cytotoxic and water-soluble bis(2-phenylazopyridine)ruthenium(II) complexes.

A. Spek, J. G. Haasnoot, M. Bacac, 2003, Journal of medicinal chemistry.

Synthesis, characterization, and crystal structure of alpha-[Ru(azpy)2(NO3)2] (azpy = 2-(phenylazo)pyridine) and the products of its reactions with guanine derivatives.

J. G. Haasnoot, J. Reedijk, A. Velders, 2000, Inorganic chemistry.

Ruthenium polypyridyl complexes containing the bischelating ligand 2,2′-azobispyridine. Synthesis, characterization and crystal structures

Duncan M. Tooke, A. Spek, J. Reedijk, 2006 .

Characterization by NMR Spectroscopy, X‐ray Analysis and Cytotoxic Activity of the Ruthenium(II) Compounds [RuL3](PF6)2(L = 2‐Phenylazopyridine or o‐Tolylazopyridine) and [RuL'2L''](PF6)2(L', L'' = 2‐Phenylazopyridine, 2,2'‐Bipyridine)

A. Spek, J. G. Haasnoot, J. Reedijk, 2005 .

cis-[PtCl2(NH3){2-(2-hydroxyethyl)pyridine}] − an Analogue of the Anticancer Drug AMD473: Unusual Hydrolysis Rates and pKa Values for the Diaqua Adduct

P. Sadler, T. Hambley, J. Parkinson, 2002 .

Stereochemical influence of the ligand on the structure of manganese complexes: implications for catalytic epoxidations.

A. Spek, E. Bouwman, R. Hage, 2005, Inorganic chemistry.

Ruthenium polypyridyl complexes and their modes of interaction with DNA: Is there a correlation between these interactions and the antitumor activity of the compounds?

H. den Dulk, A. Rodger, J. Reedijk, 2008, JBIC Journal of Biological Inorganic Chemistry.

Preparation of a new ruthenium(II) building block for the synthesis of mixed-metal complexes

J. Reedijk, A. Hotze, G. Kalayda, 2004 .

Effect of adenine moiety on DNA binding property of copper(II)-terpyridine complexes.

Zijian Guo, Q. Jiang, M. J. Hannon, 2008, Dalton transactions.

Unusual Coordination of the Rare Neutral Imine Tautomer of 9-Methyladenine Chelating in the N6,N7-Mode to Ruthenium(II) Complexes

J. G. Haasnoot, J. Reedijk, A. Velders, 2002 .

The hydrolysis of the anti-cancer ruthenium complex NAMI-A affects its DNA binding and antimetastatic activity: an NMR evaluation.

J. G. Haasnoot, M. Bacac, G. Sava, 2004, Journal of inorganic biochemistry.

Interaction between the DNA model base 9-ethylguanine and a group of ruthenium polypyridyl complexes: kinetics and conformational temperature dependence.

A. Magistrato, J. Reedijk, A. Hotze, 2007, Inorganic chemistry.

In search for anticancer compounds; new bis(2-phenylazopyridine) ruthenium(II) complexes

J. Reedijk, A. Hotze, J. Haasnoot, 2003 .

Crystallographic and NMR evidence of the unusual N6,N7-didentate chelation of 3-methyladenine coordinated to the cytotoxic -dichlorobis(2-phenylazopyridine)ruthenium(II) complex †

A. Spek, J. Reedijk, A. Velders, 2002 .